These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 349800)

  • 41. Peripheral donor leukocytes prolong survival of rat renal allografts.
    Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
    Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histocompatibility studies in a closely bred colony of dogs. 3. Genetic definition of the DL-A system of canine histocompatibility, with particular reference to the comparative immunogenicity of the major transplantable organs.
    Dausset J; Rapaport FT; Cannon FD; Ferrebee JW
    J Exp Med; 1971 Nov; 134(5):1222-37. PubMed ID: 4939370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility.
    Poehnert D; Broecker V; Mengel M; Nashan B; Koch M
    Transpl Immunol; 2010 Feb; 22(3-4):137-43. PubMed ID: 19815070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
    Wood KJ; Hopley A; Dallman MJ; Morris PJ
    Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial target cell-dependent, differing patterns of chronic vascular renal allograft rejection in the rat.
    van Breda Vriesman JC; Vlek LF; Duistermaat E; Duijvestijn AM
    Transplant Proc; 1990 Dec; 22(6):2519-21. PubMed ID: 2264132
    [No Abstract]   [Full Text] [Related]  

  • 48. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.
    Chiba K; Hoshino Y; Suzuki C; Masubuchi Y; Yanagawa Y; Ohtsuki M; Sasaki S; Fujita T
    Transplant Proc; 1996 Apr; 28(2):1056-9. PubMed ID: 8623225
    [No Abstract]   [Full Text] [Related]  

  • 49. The mechanism of platelet-induced rat renal allograft prolongation.
    Hibberd AD; Wood RA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1411-3. PubMed ID: 3274342
    [No Abstract]   [Full Text] [Related]  

  • 50. Elucidation of key peptide determinants involved in an indirect T-cell allorecognition pathway of rat kidney allograft rejection.
    Benham AM; Fabre JW
    Transplant Proc; 1995 Feb; 27(1):547-8. PubMed ID: 7879093
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat].
    Hamashima T; Yoshimura N; Matsui S; Lee CJ; Oka T
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
    Yamashita K; Masunaga T; Yanagida N; Takehara M; Hashimoto T; Kobayashi T; Echizenya H; Hua N; Fujita M; Murakami M; Furukawa H; Uede T; Todo S
    Transplantation; 2003 Oct; 76(7):1089-96. PubMed ID: 14557758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected.
    Jaskłowska-Englisz M; Olszewski WL
    Transplant Proc; 1994 Dec; 26(6):3463. PubMed ID: 7998224
    [No Abstract]   [Full Text] [Related]  

  • 54. Lymphocyte stimulation by allogeneic tissue cells in rats: with special reference to differential survival of skin and kidney allografts.
    Sakai A; Yakushiji K; Mashimo S
    Transplant Proc; 1980 Sep; 12(3 Suppl 1):74-81. PubMed ID: 7001706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Castanospermine, an alpha glucosidase inhibitor, prolongs renal allograft survival in the rat.
    Grochowicz PM; Hibberd AD; Bowen KM; Clark DA; Cowden WD; Parish CR; Willenborg DO
    Transplant Proc; 1990 Oct; 22(5):2117-8. PubMed ID: 2219314
    [No Abstract]   [Full Text] [Related]  

  • 56. Elimination of OX8+ cells prolongs cardiac but not pancreatic allograft survival across minor (non-MHC) histocompatibility barriers.
    Roza AM; Johnson CP; Adams MB; Naji A
    Transplant Proc; 1990 Apr; 22(2):747-8. PubMed ID: 2327028
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 58. Organ transplantation in the rat. The importance of the Ag-B (or H-1) locus.
    Bildsoe P
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(2):221-30. PubMed ID: 4556083
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of renal allograft rejection in the rat using purified plasma membrane and endoplasmic reticulum preparation expressing donor class I major histocompatibility complex antigen.
    Foster S; Wood KJ; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):469. PubMed ID: 3274808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.